Tirzepatide is a synthetic peptide dual receptor agonist intended solely for laboratory research and academic study. It targets GLP-1 and GIP receptors simultaneously, serving as a common research compound to explore metabolic pathways, blood glucose modulation and associated preclinical biological mechanisms.

This item appears as homogeneous white freeze-dried powder with steady physical characteristics and reliable batch-to-batch consistency. Each production batch undergoes strict quality verification via HPLC and mass spectrometry to verify molecular structure and identity. Assayed purity reaches no less than 99%. COA documents and HPLC spectra can be supplied for every batch, facilitating quality verification and full traceability for research institutions.

For lab trials, the lyophilized peptide may be reconstituted using sterile water or bacteriostatic water. It is advised to prepare the peptide solution shortly prior to experiments to preserve biological activity and prevent peptide breakdown. Reconstituted leftover solution requires appropriate storage and timely use.

Storage Guidelines: Keep sealed, undissolved lyophilized powder at -20°C under dry and dark conditions. Prevent repeated freeze-thaw cycles, which compromise peptide stability and reduce biological potency. Maintain airtight packaging, away from humidity and direct sunlight.